Liminal BioSciences Inc - Company Profile
Powered by 
All the sales intelligence you need on Liminal BioSciences Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Liminal BioSciences Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Liminal BioSciences Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Liminal BioSciences Inc (Liminal) specializes in discovering and developing novel small molecule therapeutics aimed at addressing metabolic, fibrotic, and inflammatory diseases. The company's expertise in GPCRs and focus on R&D activities is a key strength, positioning it for success in the competitive pharmaceutical landscape. However, reliance on external funding could present challenges. While the company faces threats from intense competition, rapid technological advancements, and stringent regulations, it also stands to benefit from its promising product pipeline, growing market for Type 2 diabetes disease, and the increasing demand for effective therapies, particularly in the IPF market, which is expected to see substantial growth in the coming years.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer